Date:7/24/2009

and tax benefits attributable to stock option exercises, reduced by investments in fixed assets. We feel free cash flow is a useful measure because it indicates the cash the operations of the business are generating after appropriate reinvestment for recurring investments in fixed assets that are required to operate the business. We believe this is a common financial measure useful to further evaluate the results of operations. IDEXX Laboratories, Inc. and Subsidiaries Common Stock Repurchases Amounts in thousands except per share data (Unaudited) Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2009 2008 2009 2008 ------------------------------------------------------------------------ Share repurchases during the period 593 1,002 1,061 1,952 Average price paid per share $41.72 $50.89 $37.46 $52.42 Shares remaining under repurchase authorization as of June 30, 2009 3,152

Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155

'/>"/>

SOURCE IDEXX Laboratories, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. IDEXX Laboratories to Release 2009 Second Quarter Financial Results
2. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
3. IDEXX Laboratories Announces First Quarter Results
4. IDEXX Laboratories to Release 2009 First Quarter Financial Results
5. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
6. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
7. IDEXX Laboratories Names William Brown Corporate Vice President
8. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
9. IDEXX Laboratories to Release 2008 First Quarter Financial Results
10. IDEXX Laboratories Announces Increase in Share Repurchase Program
11. IDEXX Laboratories Announces Fourth Quarter Results